Ocular Surgery in Severe Atherosclerosis: Anesthesia and Risk Stratification

Managing patients with severe atherosclerotic disease during ocular surgery requires a precise balance between preventing systemic thromboembolism and minimizing peri-operative bleeding risks. The complexity of these cases involves careful vascular risk stratification and specific anesthetic considerations to ensure patient safety.

A central challenge for ophthalmologists and anesthesiologists is determining whether to continue or suspend antithrombotic therapies. These medications, including warfarin, direct oral anticoagulants (DOACs), and antiplatelet agents, are essential for reducing the risk of life-threatening thrombosis in patients with severe vascular disease, yet they increase the potential for hemorrhage during surgical procedures.

Antithrombotic Management and Bleeding Risks

The use of antithrombotic therapy is common among patients seeking ophthalmic care. While these drugs lower the risk of systemic thromboembolism, they can complicate the surgical environment by increasing the risk of peri-operative bleeding.

In modern ophthalmic practice, general anesthesia is rarely used. Instead, many patients on antithrombotics undergo needle-based regional anesthesia. This shift in anesthetic approach places a specific focus on the risk of hemorrhage associated with needle-based techniques in patients taking blood-thinning medications.

Cardiorespiratory and Autonomic Considerations

Vascular risk stratification must also account for comorbidities that affect cardiorespiratory stability. For instance, patients undergoing retinal surgery who also have diabetes may face significant risks due to autonomic neuropathy.

Research indicates that approximately 80% of diabetic retinal surgery patients suffer from severe autonomic neuropathy. This condition increases the risk of experiencing bradycardia or sudden death during the peri-operative period.

Vascular Risk Factors in Specialized Procedures

Beyond ocular-specific surgery, the broader context of vascular surgery highlights the volatility of intraoperative hemodynamics. For example, in procedures such as carotid endarterectomy, the prediction of risk factors for intraoperative hypotension during general anesthesia is a critical component of patient safety.

Similarly, patients with heart failure who undergo major surgical procedures are associated with substantially higher risks of operative death and hospital readmission, emphasizing the need for rigorous cardiovascular screening before any surgical intervention.

Summary of Clinical Challenges

• Balancing the risk of sight- or life-threatening thrombosis against the risk of vision loss from peri-operative bleeding.
• Managing the high prevalence of autonomic neuropathy in diabetic patients to prevent bradycardia.
• Evaluating the safety of needle-based regional anesthesia for patients on antithrombotic regimens.
• Stratifying vascular risks to prevent adverse cardiorespiratory events during the surgical window.